Afrocentric Investment (JSE:ACT) PE Ratio without NRI: 4.11 (As of Jun. 26, 2026) — 45% Below Median


JSE:ACT Afrocentric Investment Corp Ltd JSE:ACT
52 GF Score
Price R0.79
GF Value R2.09
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Afrocentric Investment PE Ratio without NRI?

Afrocentric Investment JSE:ACT 52 PE Ratio without NRI is 4.11 as of Jun. 26, 2026, which is 45% below its 10-year median of 7.45. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.09 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 439 Healthcare Providers & Services companies, Afrocentric Investment ranks better than 97.49% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-06-26), Afrocentric Investment's share price is R0.79. Afrocentric Investment's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was R0.19. Therefore, Afrocentric Investment's PE Ratio without NRI for today is 4.11.

During the past 13 years, Afrocentric Investment's highest PE Ratio without NRI was 23.65. The lowest was 0.14. And the median was 7.45.

Afrocentric Investment's EPS without NRI for the six months ended in Dec. 2025 was R0.08. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was R0.19.

As of today (2026-06-26), Afrocentric Investment's share price is R0.79. Afrocentric Investment's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was R-1.52. Therefore, Afrocentric Investment's PE Ratio (TTM) for today is At Loss.

During the past years, Afrocentric Investment's highest PE Ratio (TTM) was 30.90. The lowest was 0.00. And the median was 10.29.

Afrocentric Investment's EPS (Diluted) for the six months ended in Dec. 2025 was R-1.63. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was R-1.52.

Afrocentric Investment's EPS (Basic) for the six months ended in Dec. 2025 was R-1.63. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was R-1.52.


Afrocentric Investment  (JSE:ACT) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Afrocentric Investment PE Ratio without NRI Related Terms


Afrocentric Investment PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Afrocentric Investment's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Afrocentric Investment PE Ratio without NRI Chart

Afrocentric Investment Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Dec25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.39 8.28 9.41 7.02 6.96

Afrocentric Investment Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss 7.02 At Loss At Loss 6.96

JSE:ACT vs HCA, THC, DVA: PE Ratio without NRI Comparison

For the Medical Care Facilities subindustry, Afrocentric Investment's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Afrocentric Investment PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Afrocentric Investment's PE Ratio without NRI falls into.


JSE:ACT
52GF Score
Afrocentric Investment Corp Ltd JSE:ACT
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Afrocentric Investment PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Afrocentric Investment's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=0.79/0.192
=4.11

Afrocentric Investment's Share Price of today is R0.79.
For company reported semi-annually, Afrocentric Investment's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was R0.19.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 4.11 mean?
Afrocentric Investment (JSE:ACT) has a PE Ratio without NRI of 4.11 as of Jun. 26, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Afrocentric Investment and its competitors. This is 45% below median its historical median of 7.45. Over the past decade, Afrocentric Investment's PE Ratio without NRI has ranged from 0.14 to 23.65. According to the industry distribution chart, Afrocentric Investment ranks #11 out of 439 companies in the Healthcare Providers & Services industry, placing it in the top 2.5%.
Is Afrocentric Investment's PE Ratio without NRI too high?
Afrocentric Investment's current PE Ratio without NRI of 4.11 is 45% below median its 10-year median of 7.45. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 23.65. The Healthcare Providers & Services industry median PE Ratio without NRI is 19.40. Afrocentric Investment's value of 4.11 is 78.8% below this industry median. Based on the distribution chart, Afrocentric Investment ranks #11 out of 439 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's PE Ratio without NRI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #11 out of 439 companies for PE Ratio without NRI. This places Afrocentric Investment in the top 3% of its industry — outperforming the majority of peers. The industry median PE Ratio without NRI is 19.40. Afrocentric Investment's value of 4.11 is 78.8% below this benchmark. Historically, Afrocentric Investment's own PE Ratio without NRI has ranged from 0.14 to 23.65 over the past decade. While the company's 10-year median is 7.45 vs. the industry median of 19.40, Afrocentric Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Healthcare Providers & Services company?
The median PE Ratio without NRI among Healthcare Providers & Services companies is 19.40, based on 439 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afrocentric Investment's current PE Ratio without NRI of 4.11 is 78.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Afrocentric Investment and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio without NRI is 19.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current PE Ratio without NRI is 4.11, which is 45% below median its own 10-year median of 7.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.09, compared to a current price of R0.79 — trading 62.2% below its estimated fair value. The current PE Ratio without NRI is 4.11, which is 45% below median its 10-year median of 7.45 and 78.8% below the Healthcare Providers & Services industry median of 19.40. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current PE Ratio without NRI is 4.11 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?

Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued. The current stock price of R0.79 is trading 62.2% below its estimated GF Value™ of R2.09. GuruFocus considers Afrocentric Investment to be Possible Value Trap.

Key valuation signals for JSE:ACT:

  • PE Ratio without NRI: 4.11 (45% below median its 10-year median of 7.45)
  • GF Value™: R2.09 vs. price of R0.79 (62.2% below fair value)
  • GF Score™: 52/100 with 6 warning signs
  • Industry Position: 78.8% below the Healthcare Providers & Services median (#11 of 439)

No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Afrocentric Investment Business Description

Address 37 Conrad Road, Florida North, Roodepoort, ZAF, 1709
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score

Get the complete analysis for JSE:ACT

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.79
Price
R2.09
GF Value